{{Rsnum
|rsid=9535828
|Chromosome=13
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ATP7B
|position=51999286
|Gene_s=ATP7B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 29.2 | 46.9 | 23.9
| HCB | 21.2 | 48.9 | 29.9
| JPT | 24.8 | 49.6 | 25.7
| YRI | 0.7 | 16.3 | 83.0
| ASW | 0.0 | 21.1 | 78.9
| CHB | 21.2 | 48.9 | 29.9
| CHD | 23.9 | 50.5 | 25.7
| GIH | 5.9 | 49.5 | 44.6
| LWK | 2.7 | 21.8 | 75.5
| MEX | 22.4 | 48.3 | 29.3
| MKK | 4.5 | 29.5 | 66.0
| TSI | 28.4 | 54.9 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=24852429
|Title=The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}